DR LAL PATHLABS
Back to Balance Sheet
|
DR LAL PATHLABS Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹10 Cr | ₹14 Cr | ₹13 Cr | ₹10 Cr | ₹10 Cr |
What is the latest Contingent Liabilities ratio of DR LAL PATHLABS ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹10 Cr |
Mar2023 | ₹14 Cr |
Mar2022 | ₹13 Cr |
Mar2021 | ₹10 Cr |
Mar2020 | ₹10 Cr |
How is Contingent Liabilities of DR LAL PATHLABS Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹10 Cr | -26.02 | |
Mar2023 | ₹14 Cr | 3.43 | |
Mar2022 | ₹13 Cr | 26.43 | |
Mar2021 | ₹10 Cr | 0.00 | |
Mar2020 | ₹10 Cr | - |
Compare Contingent Liabilities of peers of DR LAL PATHLABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR LAL PATHLABS | ₹20,172.7 Cr | -7.6% | -9.8% | 5.8% | Stock Analytics | |
MAX HEALTHCARE INSTITUTE | ₹99,479.3 Cr | 0.4% | 0% | 16.3% | Stock Analytics | |
APOLLO HOSPITALS ENTERPRISE | ₹89,862.5 Cr | -2.6% | -6.9% | -7.7% | Stock Analytics | |
FORTIS HEALTHCARE | ₹45,927.9 Cr | 0.8% | 4.7% | 36.4% | Stock Analytics | |
GLOBAL HEALTH | ₹32,563.5 Cr | 5.5% | 19.3% | -19% | Stock Analytics | |
NARAYANA HRUDAYALAYA | ₹29,928.6 Cr | 6.6% | 15.6% | 0.7% | Stock Analytics |
DR LAL PATHLABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR LAL PATHLABS | -7.6% |
-9.8% |
5.8% |
SENSEX | -1.8% |
-1% |
2% |
You may also like the below Video Courses